The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Opexa Therapeutics, Inc. - Developing Personalized Immunotherapies for Autoimmune Disorders: Focus on Multiple Sclerosis

SNNLive spoke with Neil K. Warma, President & CEO of Opexa Therapeutics, Inc. (NASDAQ: OPXA) at the Marcum MicroCap Conference 2015 in New York City, NY.

Share With

Tuesday, August 04, 2015

   

© 2017 Stock News Now